Supervisory board

EQS-News: ecotel communication ag: Growth in all segments – B2B business pick-ing up considerably

Retrieved on: 
Wednesday, April 10, 2024

The 2023 financial year was overall very positive for ecotel, with the company achieving its forecasts and even exceeding them in some cases.

Key Points: 
  • The 2023 financial year was overall very positive for ecotel, with the company achieving its forecasts and even exceeding them in some cases.
  • Having declined for several years due to transformation-related factors, revenues in the ecotel Business Customers segment increased to € 46.2 million in the 2023 financial year (previous year: € 45.6 million).
  • Revenues in the ecotel Wholesale segment increased significantly by € 13.6 million to € 60.1 million in the 2023 financial year.
  • As a result of this sales growth, the gross profit rose by € 0.7 million to € 1.9 million.

EQS-News: SAF-HOLLAND SE with record year and significantly increased dividend proposal

Retrieved on: 
Wednesday, April 10, 2024

In 2023, SAF-HOLLAND was able to increase Group sales by 34.6% to a new record of EUR 2,106.2 million (previous year: EUR 1,565.1 million).

Key Points: 
  • In 2023, SAF-HOLLAND was able to increase Group sales by 34.6% to a new record of EUR 2,106.2 million (previous year: EUR 1,565.1 million).
  • Adjusted EBIT increased significantly by 62.2% in the 2023 fiscal year, reaching EUR 202.1 million (previous year: EUR 124.6 million).
  • Free operating cash flow increased significantly by EUR 22.7 million compared to the previous year, from EUR 120.0 million to EUR 142.7 million.
  • In addition, the increased share of the aftermarket business should have a positive effect on margin development.

EQS-News: Hannover Re appoints Thorsten Steinmann to the Executive Board to succeed Michael Pickel, who will retire

Retrieved on: 
Wednesday, April 10, 2024

Hannover Re appoints Thorsten Steinmann to the Executive Board to succeed Michael Pickel, who will retire

Key Points: 
  • Hannover Re appoints Thorsten Steinmann to the Executive Board to succeed Michael Pickel, who will retire
    The issuer is solely responsible for the content of this announcement.
  • Hannover Re appoints Thorsten Steinmann to the Executive Board to succeed Michael Pickel, who will retire
    Hannover, 18 March 2024: The Supervisory Boards of Hannover Rück SE and E+S Rückversicherung AG have appointed Thorsten Steinmann (51) as a member of the Executive Board of Hannover Re and E+S Rück effective 1 September 2024.
  • He will succeed Michael Pickel (63), who will retire on 31 December 2024 after 25 successful years at Hannover Re.
  • I wish him every success in his new role,” said Torsten Leue, Chairman of the Supervisory Board of Hannover Re and E+S Rück.

EQS-News: Change in the Supervisory Board of Cherry SE: Harald von Heynitz succeeds Joachim Coers

Retrieved on: 
Wednesday, April 10, 2024

Change in the Supervisory Board of Cherry SE: Harald von Heynitz succeeds Joachim Coers

Key Points: 
  • Change in the Supervisory Board of Cherry SE: Harald von Heynitz succeeds Joachim Coers
    The issuer is solely responsible for the content of this announcement.
  • Munich, April 10, 2024 - The Supervisory Board of Cherry SE will be reconstituted: Joachim Coers had resigned his mandate as of December 31, 2023.
  • Harald von Heynitz was appointed with effect from April 5 until the Annual General Meeting on June 14, 2024, by the Munich court.
  • At the same time, we would like to thank Joachim Coers for his valuable work for the Supervisory Board of Cherry SE."

EQS-News: Heidelberg Pharma announces financial figures and reports on successful business performance in 2023

Retrieved on: 
Wednesday, April 10, 2024

Minority interest in Emergence sold: In summer 2023, Heidelberg Pharma sold its minority interest in Emergence Therapeutics AG, Duisburg, Germany, (Emergence).

Key Points: 
  • Minority interest in Emergence sold: In summer 2023, Heidelberg Pharma sold its minority interest in Emergence Therapeutics AG, Duisburg, Germany, (Emergence).
  • As a result, Heidelberg Pharma lost sales revenue in the low single-digit millions for the 2023 financial year.
  • In April 2023, Heidelberg Pharma signed a termination agreement with Magenta under which all licensed ATAC rights and some Magenta patents were assumed by Heidelberg Pharma.
  • The Heidelberg Pharma Group includes two entities, Heidelberg Pharma AG and Heidelberg Pharma Research GmbH.

EQS-News: Rational AG increases its sales revenues by 10 percent to 1.126 billion euros – the outlook is optimistic

Retrieved on: 
Wednesday, April 10, 2024

Rational had already reported strong figures for sales revenues and earnings in the first nine months of 2023.

Key Points: 
  • Rational had already reported strong figures for sales revenues and earnings in the first nine months of 2023.
  • As a result, sales revenues for 2023 increased overall by 103.5 million euros, which corresponds to a growth of 10 percent.
  • With an increase of 13 percent, sales revenues in the iCombi product group exceeded the billion mark for the first time.
  • The cost of sales therefore rose more slowly than sales revenues, by 7percent to 487.2 million euros (2022: 457.3 million euros).

EQS-News: Positive developments in Vonovia’s core business with disposals well above target and confident outlook for 2024 financial year

Retrieved on: 
Wednesday, April 10, 2024

EBT (Adjusted Earnings Before Taxes) from 2024 leading measure of earnings; OFCF (Operating Free Cashflow) as key metric of internal financing.

Key Points: 
  • EBT (Adjusted Earnings Before Taxes) from 2024 leading measure of earnings; OFCF (Operating Free Cashflow) as key metric of internal financing.
  • Expectations for 2024: disposals worth €3 billion, higher investments in energy-efficient modernization and faster expansion of solar panels.
  • Bochum, 14 March 2024 - As expected, Vonovia SE’s (“Vonovia”) performance developed robustly in 2023.
  • In 2023, Vonovia realised disposals (including joint venture structures) with a volume of around €4 billion – twice as much as the company’s initial target.

EQS-News: SINGULUS TECHNOLOGIES publishes annual financial statements 2023

Retrieved on: 
Wednesday, April 10, 2024

Kahl am Main, April 8, 2024 - The Supervisory Board of SINGULUS TECHNOLOGIES AG approved the annual financial statements, the consolidated financial statements, and the combined status report of the company for the business year 2023 on April 4, 2024, and adopted the annual financial statements.

Key Points: 
  • Kahl am Main, April 8, 2024 - The Supervisory Board of SINGULUS TECHNOLOGIES AG approved the annual financial statements, the consolidated financial statements, and the combined status report of the company for the business year 2023 on April 4, 2024, and adopted the annual financial statements.
  • The annual financial statements for 2023 were published today, April 8, 2024, on the Company's website at: https://www.singulus.com/financial-reports/.
  • SINGULUS TECHNOLOGIES, a leading supplier of machines and systems for the semiconductor industry, has received orders for several innovative TIMARIS coating systems in recent weeks.
  • For 2024, SINGULUS TECHNOLOGIES expects a significant increase in sales compared to 2023.

EQS-News: secunet Security Networks AG: Audited annual financial statements and annual report for 2023 and forecast for 2024

Retrieved on: 
Wednesday, April 10, 2024

[Essen / Germany, 22 March 2024] secunet Security Networks AG (ISIN DE0007276503, WKN 727650), Germany's leading cybersecurity company and IT security partner of the Federal Republic of Germany, today published its audited annual financial statements and annual report for 2023 as well as its forecast for 2024.

Key Points: 
  • [Essen / Germany, 22 March 2024] secunet Security Networks AG (ISIN DE0007276503, WKN 727650), Germany's leading cybersecurity company and IT security partner of the Federal Republic of Germany, today published its audited annual financial statements and annual report for 2023 as well as its forecast for 2024.
  • secunet Group's earnings before interest and taxes (EBIT) amounted to 43.0 million euros in the 2023 financial year (previous year: 47.0 million euros).
  • In the 2023 financial year, secunet Group generated consolidated net income for the period of 29.0 million euros (previous year: 31.3 million euros).
  • The net income of secunet Security Networks AG under German commercial law amounted to 30.5 million euros (previous year: 36.9 million euros).

EQS-News: CANCOM SE: CANCOM publishes Annual Report 2023 and forecasts significant growth

Retrieved on: 
Wednesday, April 10, 2024

Munich, Germany, 28 March 2024 – In the 2023 financial year, Group revenue increased by 17.8 percent to € 1,522.7 million.

Key Points: 
  • Munich, Germany, 28 March 2024 – In the 2023 financial year, Group revenue increased by 17.8 percent to € 1,522.7 million.
  • The CANCOM Group also achieved a significant increase in gross profit of 33.0 percent to € 582.3 million (prior year: € 437.9 million).
  • "Thanks to our successful acquisition strategy, we closed the 2023 financial year with significant growth," summarises Rüdiger Rath, CEO of CANCOM SE.
  • The first joint annual financial statements published with the annual report are another important milestone in the integration of the two companies.